Page last updated: 2024-10-31

neostigmine and Hypertrophy

neostigmine has been researched along with Hypertrophy in 3 studies

Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.

Hypertrophy: General increase in bulk of a part or organ due to CELL ENLARGEMENT and accumulation of FLUIDS AND SECRETIONS, not due to tumor formation, nor to an increase in the number of cells (HYPERPLASIA).

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19902 (66.67)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
STRAFFON OSORNO, AE1
TREVINO, H1
Grisoni, E1
De Agustin, JC1
Kalhan, SC1
Cocker, J1
Thomson, RM1

Other Studies

3 other studies available for neostigmine and Hypertrophy

ArticleYear
[Diagnostic value of neostigmine in congenital hypertrophy of the pylorus].
    Medicina, 1955, Aug-10, Volume: 35, Issue:729

    Topics: Constriction, Pathologic; Hypertrophy; Neostigmine; Pylorus

1955
Vasoactive intestinal polypeptide causes relaxation of the pyloric sphincter in the rabbit.
    Journal of pediatric surgery, 1993, Volume: 28, Issue:9

    Topics: Animals; Dose-Response Relationship, Drug; Hypertrophy; Muscle Contraction; Neostigmine; Pyloric Ste

1993
Multiple smooth muscle hypertrophies in a newborn infant.
    Archives of disease in childhood, 1966, Volume: 41, Issue:219

    Topics: Abnormalities, Drug-Induced; Adult; Female; Gastrointestinal Diseases; Humans; Hypertrophy; Infant,

1966